Early Feasibility Study for Critical Limb Ischaemia intervention device into US Markets

危重肢体缺血干预装置进入美国市场的早期可行性研究

• 批准号: 10018670
• 金额: $ 2.36万
• 依托单位: RUA LIFE SCIENCES PLC
• 依托单位国家: 英国
• 项目类别: Collaborative R&D
• 财政年份: 2022
• 资助国家: 英国
• 起止时间: 2022 至 无数据
• 项目状态: 已结题
• 来源: https://gtr.ukri.org/projects?ref=10018670
• 关键词: Early; Feasibility; Study; Critical; Limb

The project is designed to establish the commercial viability and potential for market launch of a novel vascular graft specifically designed to improve graft durability and the outcomes for patients requiring surgical intervention for critical limb ischemia. The graft will utilise the proven biocompatibility and non-thrombogenic nature of Elast-Eon together with the implantable textiles expertise of the RUA Life Science group entities. Activities to be undertaken during the feasibility study are to deepen the relationship with a current US based manufacturing partner, engage with end user surgeons and identify commercial partners for distributing the novel device into the US market.

该项目旨在建立商业生存能力和市场推出的潜力，专门设计用于提高移植耐用性和需要手术干预以治疗严重肢体缺血的患者的结果。移植物将利用弹性弹子的验证生物相容性和非控制性性质以及RUA Life Science Group实体的可植入纺织品专业知识。在可行性研究期间要进行的活动是为了加深与现任美国制造合作伙伴的关系，与最终用户外科医生互动，并确定商业合作伙伴将新型设备分配到美国市场。